Precision DTIL 深 沪
等待开盘 10-06 09:30:00 美东时间
6.31
0.000
0.00%
华盛通- 最 高8.82
- 今 开6.36
- 成交量 18.76万股
- 最 低 5.99
- 昨 收 6.31
- 总市值 39.23万
- 52周最高 9.62
- 市盈率 静 --
- 换手率 301.74%
- 52周最低 3.53
- 委 比 -94.34%
- 总股本 6.22万
- 历史最高 710.10
- 量 比 0.91
- 振 幅 44.85%
- 历史最低 3.53
- 每 手 1
- 风险率 1.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cardinal Health, McKesson Double Down on CVS Deals Through 2032
Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.
10-01 23:59
Ondas Adds Critical Weapons Tech In $205 Million Deal
Ondas (ONDS) acquires GATE Technologies and Bron for $205M to expand its precision-strike and autonomous defense portfolio.
09-15 01:06
AeroVironment Reports Q1 2027 Results: Full Earnings Call Transcript
AeroVironment (NASDAQ:AVAV) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
09-10 06:24
Why AGCO Stock May Be Mispriced
Overview AGCO Corporation (NYSE:AGCO) is a manufacturer of agricultural machinery, with brands including Fendt, Massey Ferguson, and Valtra. Despite its global footprint and growing precision agriculture business,
07-28 17:58
Why Is Profusa Stock Falling Monday?
PFSA stock fell 18.5% in premarket trading after Profusa named a new CEO and signed a deal to acquire a $111M diagnostics firm.
07-27 19:46
FACT II Acquisition Terminates Proposed Merger With Precision Aerospace & Defense Group
"Throughout this process, we worked diligently to assemble the capital required to complete the transaction and were pleased to have received multiple financing proposals on favorable market terms that would have in
07-22 04:20
Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia
The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of Neogen's genomics unit due to competition concerns.
07-17 21:57
Catheter Precision Reports Preliminary Q2 Revenue Of $1.037M
Catheter Precision, Inc. (VTAK: NYSE/American), today announced preliminary unaudited record revenues of $1,037,000 for the quarter ended June 30, 2026, including both the MedTech segment and the Flyte Vision Jet
07-15 20:02
Catheter Precision Plunges as Traders Unwind Gains from Recent News
Catheter Precision Stock falls sharply as traders reverse gains tied to Flyte news and recent patent updates.
07-10 23:19
Crude Oil Jumps 6%; US Wholesale Inventories Rise 0.1% In May
Dow falls over 1% as stocks trade lower. Energy shares surge, materials stocks decline. Wholesale inventories and mortgage applications decline.
07-09 00:56
